Feasibility Study of a Remote Behavioral Dietary Intervention in Patients With Early to Intermediate AMD: Glucose Lowering for Vision Extension

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age55-75
SponsorStanford University

About this trial

The primary goal of the study is to test dietary intervention at glycemic control and carotenoid levels in participants with intermediate age-related macular degeneration.

Eligibility criteria

Qualifiers

Diagnosis of early to intermediate AMD with no history of retinal geographic atrophy (cRORA) or exudative disease

Eating a diet less healthy than average (Healthy Eating Index [HEI] score <61) based on 3 24-hour dietary recalls

Access to a computer or smart phone for use in the behavioral meetings (we will provide loaners for those lacking a smart phone

Because the initial questionnaires (ASA24), surveys and informed consent will be on line and in English, only individuals with fluency in English will be included. (They do not need to list English as their primary language.)

Disqualifiers

HbA1c greater than 6.5%,

Diabetes or medications used to treat diabetes or obesity (including GLP1 agonists, metformin, glyburide

Use of statins, niacin or other lipid/cholesterol modifying medications

Recent cancer (within past 3 years)

Trial design

Treatments tested in this trial

  • Low glycemic Mediterranean diet behavioral modification

Treatment groups

32 Participants
are divided into 1 treatment group

Sponsors and collaborators

Stanford University

Lead sponsor

National Eye Institute (NEI)

Collaborator